Pan-cancer Myc modulator that targets Myc-α-tubulin interaction to drive selective mitotic catastrophe
8.0
来源：
Nature
关键字：
ML brain science
发布时间：
2025-11-01 03:38
摘要：
DL78 is identified as a potent Myc modulator that selectively induces mitotic catastrophe in high-grade serous ovarian cancer (HGSC) by disrupting the interaction between Myc and α-tubulin. This compound shows broad efficacy across various cancer types and has the potential to address the urgent need for novel therapies in ovarian cancer, particularly in cases of chemoresistance. The study highlights DL78's unique mechanism of action, making it a promising candidate for further development and investment in the oncology sector.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0
business_impact
1.0
scientific_rigor
1.5
timeliness_innovation
1.5
investment_perspective
2.5
market_value_relevance
1.0
team_institution_background
0.5
technical_barrier_competition
1.0
关键证据
DL78 demonstrated broad efficacy by inhibiting growth across nine cancer types.
DL78 preferentially targets MYC-overexpressing cancer cells, leading to mitotic catastrophe.
The study establishes a novel paradigm for Myc-targeted therapy.
真实性检查
否
AI评分总结
DL78 is identified as a potent Myc modulator that selectively induces mitotic catastrophe in high-grade serous ovarian cancer (HGSC) by disrupting the interaction between Myc and α-tubulin. This compound shows broad efficacy across various cancer types and has the potential to address the urgent need for novel therapies in ovarian cancer, particularly in cases of chemoresistance. The study highlights DL78's unique mechanism of action, making it a promising candidate for further development and investment in the oncology sector.